SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-028413
Filing Date
2024-06-17
Accepted
2024-06-17 09:01:14
Documents
16
Period of Report
2024-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20240614.htm   iXBRL 8-K 46329
2 EX-10.1 ardelyx-amendedandrestated.htm EX-10.1 110681
3 EX-10.2 ardelyx-amendedandrestateda.htm EX-10.2 240041
7 ardx-20240614_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-24-028413.txt   552277

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240614.xsd EX-101.SCH 1901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240614_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240614_pre.xml EX-101.PRE 13046
19 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240614_htm.xml XML 2892
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 241047077
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)